RecruitingPhase 3NCT04965675
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Sponsor: H. Lundbeck A/S
Cincinnati, OH · +21 more sites
Migraine clinical trials in Cincinnati, OH
15 recruiting migraine studies with a site in Cincinnati, OH.
RecruitingPhase 3NCT05156398
Efficacy and Safety Study of Rimegepant for the Preventative Treatment of Migraine in Pediatric Subjects
Sponsor: Pfizer
Cincinnati, OH · +54 more sites
RecruitingPhase 3NCT05164172
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Sponsor: H. Lundbeck A/S
Akron, OH · Cincinnati, OH · +18 more sites
RecruitingPhase 3NCT05897320
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
Sponsor: H. Lundbeck A/S
Akron, OH · Cincinnati, OH · +13 more sites
RecruitingPhase 3NCT07816367
A Study to Assess the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
Sponsor: Kallyope Inc.
Beachwood, OH · Blue Ash, OH · Cincinnati, OH · +69 more sites
RecruitingPhase 3NCT05711394
A Study to Assess the Adverse Events and Change in Disease Activity of Oral Atogepant Tablets in Pediatric Participants (6-17 Years of Age) With Episodic Migraine
Sponsor: AbbVie
Cincinnati, OH · West Chester, OH · +39 more sites
RecruitingPhase 1NCT06995729
A Study to Learn About the Study Medicine Called Zavegepant (PF-07930207) in Children With a History of Migraine
Sponsor: Pfizer
Cincinnati, OH · +13 more sites
RecruitingPhase 3NCT04649242
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Sponsor: Pfizer
Akron, OH · Cincinnati, OH · +166 more sites
RecruitingPhase 3NCT04743141
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
Sponsor: Pfizer
Cincinnati, OH · +112 more sites
RecruitingNot applicableNCT05889624
Responding With Evidence and Access for Childhood Headaches
Sponsor: Children's Hospital Medical Center, Cincinnati
Cincinnati, OH · Columbus, OH · +13 more sites
RecruitingPhase 3NCT05125302
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
Sponsor: AbbVie
Cincinnati, OH · +122 more sites
RecruitingNot applicableNCT05987592
BE WELL With Migraine: Brain Education and WELLness With Migraine
Sponsor: Wake Forest University Health Sciences
Cincinnati, OH · +2 more sites
RecruitingNot applicableNCT05814497
Supraspinal Processing of Sensory Aspects of Pain
Sponsor: Children's Hospital Medical Center, Cincinnati
Cincinnati, OH
RecruitingPhase 4NCT04748601
Qudexy XR for the Prevention of Migraine in Children 6 to 11 Years Old
Sponsor: Upsher-Smith Laboratories
Cincinnati, OH · +14 more sites
RecruitingPhase not listedNCT05752396
Overlapping Pain Trajectory Study
Sponsor: Children's Hospital Medical Center, Cincinnati
Cincinnati, OH
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.